Sand Hill Global Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $294K | Sell |
2,287
-162
| -7% | -$19K | 0.01% | 185 |
|
|
2026
Q1 | $295K | Buy |
2,449
+145
| +6% | +$16.7K | 0.01% | 170 |
|
|
2025
Q4 | $243K | Buy |
+2,304
| New | +$216K | 0.01% | 182 |
|
|
2025
Q3 | – | Sell |
-2,910
| Closed | -$230K | – | 208 |
|
|
2025
Q2 | $230K | Sell |
2,910
-1,752
| -38% | -$139K | 0.01% | 187 |
|
|
2025
Q1 | $418K | Buy |
4,662
+827
| +22% | +$77.2K | 0.02% | 152 |
|
|
2024
Q4 | $382K | Sell |
3,835
-201
| -5% | -$20.7K | 0.02% | 152 |
|
|
2024
Q3 | $458K | Sell |
4,036
-33
| -0.8% | -$3.92K | 0.02% | 143 |
|
|
2024
Q2 | $504K | Buy |
4,069
+680
| +20% | +$87.6K | 0.02% | 136 |
|
|
2024
Q1 | $447K | Buy |
3,389
+33
| +1% | +$4.07K | 0.02% | 123 |
|
|
2023
Q4 | $366K | Sell |
3,356
-361
| -10% | -$37.5K | 0.02% | 133 |
|
|
2023
Q3 | $383K | Sell |
3,717
-64
| -2% | -$6.9K | 0.02% | 119 |
|
|
2023
Q2 | $436K | Sell |
3,781
-117
| -3% | -$13.3K | 0.02% | 120 |
|
|
2023
Q1 | $415K | Buy |
3,898
+1
| +0% | +$108 | 0.02% | 126 |
|
|
2022
Q4 | $432K | Sell |
3,897
-227
| -6% | -$23.2K | 0.02% | 130 |
|
|
2022
Q3 | $355K | Buy |
4,124
+77
| +2% | +$6.87K | 0.02% | 129 |
|
|
2022
Q2 | $369K | Sell |
4,047
-35,620
| -90% | -$3.16M | 0.02% | 128 |
|
|
2022
Q1 | $3.25M | Buy |
39,667
+3,088
| +8% | +$243K | 0.18% | 66 |
|
|
2021
Q4 | $2.8M | Buy |
36,579
+395
| +1% | +$31.5K | 0.16% | 72 |
|
|
2021
Q3 | $2.72M | Sell |
36,184
-456
| -1% | -$34.7K | 0.17% | 67 |
|
|
2021
Q2 | $2.85M | Sell |
36,640
-1,199
| -3% | -$89.2K | 0.17% | 67 |
|
|
2021
Q1 | $2.78M | Buy |
37,839
+5,139
| +16% | +$379K | 0.18% | 65 |
|
|
2020
Q4 | $2.55M | Sell |
32,700
-2,257
| -6% | -$173K | 0.17% | 65 |
|
|
2020
Q3 | $2.77M | Sell |
34,957
-706
| -2% | -$55.3K | 0.21% | 57 |
|
|
2020
Q2 | $2.63M | Sell |
35,663
-386
| -1% | -$29.1K | 0.21% | 61 |
|
|
2020
Q1 | $2.65M | Buy |
36,049
+29,298
| +434% | +$2.3M | 0.25% | 55 |
|
|
2019
Q4 | $586K | Buy |
6,751
+961
| +17% | +$78.9K | 0.05% | 94 |
|
|
2019
Q3 | $465K | Buy |
5,790
+1,760
| +44% | +$141K | 0.04% | 101 |
|
|
2019
Q2 | $322K | Buy |
+4,030
| New | +$309K | 0.03% | 90 |
|
|
2014
Q3 | – | Sell |
-3,641
| Closed | -$201K | – | 80 |
|
|
2014
Q2 | $201K | Buy |
+3,641
| New | +$199K | 0.04% | 78 |
|
Other funds holding MRK
Sand Hill Global Advisors's MRK Position: Q2 2026 in Review
Sand Hill Global Advisors reduced its Merck (MRK) stake by 6.6% in Q2 2026, selling an estimated $19K and leaving 2,287 shares worth $294K. The position accounts for 0.01% of the portfolio, ranked #185.
Sand Hill Global Advisors first reported a position in MRK in Q2 2014 and has held it in 29 quarters since. The position peaked at $3.25M in Q1 2022. 3,836 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Sand Hill Global Advisors held 2,287 shares of Merck worth $294K as of Q2 2026.
- Sand Hill Global Advisors sold 162 Merck shares in Q2 2026, an estimated $19K.
- Merck made up 0.01% of Sand Hill Global Advisors's portfolio in Q2 2026, its #185 holding.
- Sand Hill Global Advisors first reported a position in Merck in Q2 2014 and has held it in 29 quarters since.
- Sand Hill Global Advisors's Merck position peaked at $3.25M in Q1 2022.
- 3,836 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Sand Hill Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.